Boutique Biotech

Share this post

Affimed in the spotlight

boutiquebiotech.substack.com

Affimed in the spotlight

Will the AFM13+NK trial be registrational? When will $AFMD report AFM24 + PD-L1 and AFM24+autologous NK data?

Bohdan (Bo) Khomtchouk, Ph.D.
Mar 24, 2023
∙ Paid
Share

Boutique Biotech has been following Affimed ($AFMD) since 2021 (see our archive). The Company announced a rather disappointing update yesterday. There was not much clarity shared and it seemed like AFM24 was seeing more data delays.

The main questions surrounding Affimed (below) that did not receive any clarity during the full-year 2022 update were:

  1. Will …

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2023 Bohdan (Bo) Khomtchouk, Ph.D.
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing